Home
COLL
COLL News

Latest Collegium Pharmaceutical Inc. (COLL) News on July 27, 2024

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire

2 days ago

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

Argus Research

3 days ago

COLL: Raising target price to $35.00

Argus Research

10 days ago

COLL: Raising target price to $34.00

Argus Research

17 days ago

COLL: Lowering target price to $33.00

Collegium Pharmaceutical (NASDAQ:COLL) shareholders have earned a 19% CAGR over the last five years

Simply Wall St.

a month ago

Collegium Pharmaceutical (NASDAQ:COLL) shareholders have earned a 19% CAGR over the last five years

MT Newswires

a month ago

Collegium Pharmaceutical Says Nucynta Gets FDA Pediatric Exclusivity

Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise

GlobeNewswire

a month ago

Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Upgraded by Jefferies

Insider Monkey

2 months ago

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Upgraded by Jefferies

Investing.com

2 months ago

Street calls of the week: Upgrades for Best Buy and Lululemon

Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 25,000 Shares of Collegium ...

GuruFocus.com

2 months ago

Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 25,000 Shares of Collegium ...

MT Newswires

2 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $814,180, According to a Recent SEC Filing

Insider Sale: EVP & CFO Colleen Tupper Sells Shares of Collegium Pharmaceutical Inc (COLL)

GuruFocus.com

2 months ago

Insider Sale: EVP & CFO Colleen Tupper Sells Shares of Collegium Pharmaceutical Inc (COLL)

Collegium to Participate in Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Collegium to Participate in Jefferies Global Healthcare Conference

MT Newswires

2 months ago

Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program

Collegium Announces $35 Million Accelerated Share Repurchase Program

GlobeNewswire

2 months ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

Collegium Pharmaceutical Reports First Quarter 2024 Earnings

GuruFocus.com

3 months ago

Collegium Pharmaceutical Reports First Quarter 2024 Earnings

Associated Press Finance

3 months ago

Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

Associated Press

3 months ago

Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

MT Newswires

3 months ago

--Needham Downgrades Collegium Pharmaceutical to Hold From Buy

Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet

Simply Wall St.

3 months ago

Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet

MT Newswires

3 months ago

Collegium Pharmaceutical Q1 Adjusted Net Income, Revenue Rise; 2024 Outlook Reiterated

Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

3 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates

Zacks

3 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates

Associated Press Finance

3 months ago

Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Reports First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Collegium Reports First Quarter 2024 Financial Results

Collegium Announces CEO Transition

GlobeNewswire

3 months ago

Collegium Announces CEO Transition

Unlocking Q1 Potential of Collegium Pharmaceutical (COLL): Exploring Wall Street Estimates for Key Metrics

Zacks

3 months ago

Unlocking Q1 Potential of Collegium Pharmaceutical (COLL): Exploring Wall Street Estimates for Key Metrics

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

3 months ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Collegium (COLL) to Report Q1 Earnings: Here's What to Expect

Zacks

3 months ago

Collegium (COLL) to Report Q1 Earnings: Here's What to Expect

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

GlobeNewswire

3 months ago

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

GlobeNewswire

3 months ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Argus Research

3 months ago

COLL: Rating increased to a BUY

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?

Simply Wall St.

3 months ago

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

GlobeNewswire

4 months ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know

Zacks

4 months ago

Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

4 months ago

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

Zacks

4 months ago

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

Zacks.com featured highlights AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron

Zacks

4 months ago

Zacks.com featured highlights AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

Zacks

4 months ago

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth Stock

Zacks

4 months ago

3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth Stock

Are You Looking for a Top Momentum Pick? Why Collegium Pharmaceutical (COLL) is a Great Choice

Zacks

5 months ago

Are You Looking for a Top Momentum Pick? Why Collegium Pharmaceutical (COLL) is a Great Choice

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Zacks

5 months ago

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Best Value Stocks to Buy for February 29th

Zacks

5 months ago

Best Value Stocks to Buy for February 29th

Insider Sell: EVP & Chief Commercial Officer Scott Dreyer Sells 10,000 Shares of Collegium ...

GuruFocus.com

5 months ago

Insider Sell: EVP & Chief Commercial Officer Scott Dreyer Sells 10,000 Shares of Collegium ...

This Unsung Pharmaceutical Stock In The IBD 50 Hit A Buy Zone. Here's Why.

Investor's Business Daily

5 months ago

This Unsung Pharmaceutical Stock In The IBD 50 Hit A Buy Zone. Here's Why.

Collegium Pharmaceutical Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

5 months ago

Collegium Pharmaceutical Full Year 2023 Earnings: EPS Beats Expectations

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Collegium Pharmaceutical Inc Earnings Call

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q4 Earnings

Zacks

5 months ago

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q4 Earnings

Associated Press Finance

5 months ago

Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical Inc Reports Record Earnings for Q4 and Full-Year 2023

GuruFocus.com

5 months ago

Collegium Pharmaceutical Inc Reports Record Earnings for Q4 and Full-Year 2023

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire

5 months ago

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

13 Best Short Squeeze Stocks To Buy Now

Insider Monkey

5 months ago

13 Best Short Squeeze Stocks To Buy Now

Analysts Estimate Recursion Pharmaceuticals (RXRX) to Report a Decline in Earnings: What to Look Out for

Zacks

5 months ago

Analysts Estimate Recursion Pharmaceuticals (RXRX) to Report a Decline in Earnings: What to Look Out for

ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock?

Zacks

6 months ago

ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock?

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

GlobeNewswire

6 months ago

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Why Medical Properties Trust Stock Crashed 37% in January

Motley Fool

6 months ago

Why Medical Properties Trust Stock Crashed 37% in January

Cimpress (CMPR) Shares Rise 1.9% Since Q2 Earnings Release

Zacks

6 months ago

Cimpress (CMPR) Shares Rise 1.9% Since Q2 Earnings Release

NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

6 months ago

NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Mortgage Rates Tick Down

GlobeNewswire

6 months ago

Mortgage Rates Tick Down

Pros Holdings (PRO) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

6 months ago

Pros Holdings (PRO) Reports Next Week: Wall Street Expects Earnings Growth

Here's What Key Metrics Tell Us About Brinker International (EAT) Q2 Earnings

Zacks

6 months ago

Here's What Key Metrics Tell Us About Brinker International (EAT) Q2 Earnings

Reasons to Invest in Collegium Pharmaceutical (COLL)

Insider Monkey

6 months ago

Reasons to Invest in Collegium Pharmaceutical (COLL)

WesBanco Declares Quarterly Cash Dividend upon Its Perpetual Preferred Stock

PR Newswire

6 months ago

WesBanco Declares Quarterly Cash Dividend upon Its Perpetual Preferred Stock

Director ZERBE ROBERT L MD Sells 8,000 Shares of Vericel Corp (VCEL)

GuruFocus.com

6 months ago

Director ZERBE ROBERT L MD Sells 8,000 Shares of Vericel Corp (VCEL)

Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again

Zacks

6 months ago

Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again

Q3 Earnings Highs And Lows: Home Depot (NYSE:HD) Vs The Rest Of The Home Furnishing and Improvement Retail Stocks

StockStory

6 months ago

Q3 Earnings Highs And Lows: Home Depot (NYSE:HD) Vs The Rest Of The Home Furnishing and Improvement Retail Stocks

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

StockStory

6 months ago

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

Expro Awarded Contract With INPEX for Carbon Capture Utilization and Storage Pilot Project

Business Wire

6 months ago

Expro Awarded Contract With INPEX for Carbon Capture Utilization and Storage Pilot Project

Vericel Corp President and CEO Dominick Colangelo Sells 33,452 Shares

GuruFocus.com

6 months ago

Vericel Corp President and CEO Dominick Colangelo Sells 33,452 Shares

How Are Rate Hikes Aiding Allstate (ALL) to Fight Inflation?

Zacks

6 months ago

How Are Rate Hikes Aiding Allstate (ALL) to Fight Inflation?

Q3 Earnings Highs And Lows: RH (NYSE:RH) Vs The Rest Of The Home Furniture Retailer Stocks

StockStory

6 months ago

Q3 Earnings Highs And Lows: RH (NYSE:RH) Vs The Rest Of The Home Furniture Retailer Stocks

EVP & Chief Commercial Officer Scott Dreyer Sells 23,560 Shares of Collegium Pharmaceutical Inc

GuruFocus.com

6 months ago

EVP & Chief Commercial Officer Scott Dreyer Sells 23,560 Shares of Collegium Pharmaceutical Inc

Earnings Preview: SouthState (SSB) Q4 Earnings Expected to Decline

Zacks

6 months ago

Earnings Preview: SouthState (SSB) Q4 Earnings Expected to Decline

LyondellBasell (LYB) Inks PPAs to Meet Renewable Energy Goal

Zacks

6 months ago

LyondellBasell (LYB) Inks PPAs to Meet Renewable Energy Goal

LyondellBasell (LYB) Enters Into Deal to Buy 35% of NATPET

Zacks

6 months ago

LyondellBasell (LYB) Enters Into Deal to Buy 35% of NATPET

Synchrony (SYF) Strengthens Ties to Offer Improved Health Care

Zacks

6 months ago

Synchrony (SYF) Strengthens Ties to Offer Improved Health Care

Verisk Publishes 2023 Task Force on Climate-Related Financial Disclosures (TCFD) Report

GlobeNewswire

7 months ago

Verisk Publishes 2023 Task Force on Climate-Related Financial Disclosures (TCFD) Report

Maritime Moneymakers: 3 Shipping Stocks to Ride the Trade Wave

InvestorPlace

7 months ago

Maritime Moneymakers: 3 Shipping Stocks to Ride the Trade Wave

Why Collegium Pharmaceutical (COLL) Stock Might be a Great Pick

Zacks

7 months ago

Why Collegium Pharmaceutical (COLL) Stock Might be a Great Pick

Liberty All-Star® Equity Fund Declares Distribution

PR Newswire

7 months ago

Liberty All-Star® Equity Fund Declares Distribution

Alignment Healthcare Delivers 44% Year-Over-Year Membership Growth Following Significant Boost from AEP, Increasing Membership to 155,500

GlobeNewswire

7 months ago

Alignment Healthcare Delivers 44% Year-Over-Year Membership Growth Following Significant Boost from AEP, Increasing Membership to 155,500

Zacks Industry Outlook Highlights Alarm.com, Brady, Napco Security Technologies and Lakeland Industries

Zacks

7 months ago

Zacks Industry Outlook Highlights Alarm.com, Brady, Napco Security Technologies and Lakeland Industries

Kymera Therapeutics Announces Pricing of $275 Million Public Offering

GlobeNewswire

7 months ago

Kymera Therapeutics Announces Pricing of $275 Million Public Offering

Myriad Genetics, Inc.'s (NASDAQ:MYGN) Intrinsic Value Is Potentially 221% Above Its Share Price

Simply Wall St.

7 months ago

Myriad Genetics, Inc.'s (NASDAQ:MYGN) Intrinsic Value Is Potentially 221% Above Its Share Price

Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?

Zacks

7 months ago

Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?

Kymera Therapeutics Announces Proposed Public Offering

GlobeNewswire

7 months ago

Kymera Therapeutics Announces Proposed Public Offering

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Zacks

7 months ago

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Collegium (COLL) Shares Rise on Financial Outlook for 2024

Zacks

7 months ago

Collegium (COLL) Shares Rise on Financial Outlook for 2024

Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?

Zacks

7 months ago

Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?

Xerox layoffs, Xponential Fitness downgrade: Trending Stocks

Yahoo Finance Video

7 months ago

Xerox layoffs, Xponential Fitness downgrade: Trending Stocks

Collegium Provides 2024 Financial Guidance

GlobeNewswire

7 months ago

Collegium Provides 2024 Financial Guidance

Live Nation (LYV) Stock Up 35% in a Year: More Room to Run?

Zacks

7 months ago

Live Nation (LYV) Stock Up 35% in a Year: More Room to Run?

Institutional Property Advisors Closes $80 Million Multifamily Asset Sale in Gilbert, Arizona

Business Wire

7 months ago

Institutional Property Advisors Closes $80 Million Multifamily Asset Sale in Gilbert, Arizona

Prediction: You Won't Regret Buying These 3 No-Brainer High-Yield Dividend Stocks

Motley Fool

7 months ago

Prediction: You Won't Regret Buying These 3 No-Brainer High-Yield Dividend Stocks

Collegium Pharmaceutical Inc CEO Joseph Ciaffoni Sells Company Shares

GuruFocus.com

7 months ago

Collegium Pharmaceutical Inc CEO Joseph Ciaffoni Sells Company Shares

Why Soleno Therapeutics Stock Ticked Higher on Thursday

Motley Fool

7 months ago

Why Soleno Therapeutics Stock Ticked Higher on Thursday

Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%

Benzinga

7 months ago

Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%

VEON Presents Digital Operator Success Story at NSR/BCG Investor Conference in New York

GlobeNewswire

7 months ago

VEON Presents Digital Operator Success Story at NSR/BCG Investor Conference in New York

Investors Don't See Light At End Of Cinemark Holdings, Inc.'s (NYSE:CNK) Tunnel

Simply Wall St.

7 months ago

Investors Don't See Light At End Of Cinemark Holdings, Inc.'s (NYSE:CNK) Tunnel

Share on Social Networks: